150 results on '"Saggar, Rajan"'
Search Results
2. Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning
3. Atrial Arrhythmias in Patients With Pulmonary Hypertension
4. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells
5. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
6. REFRACTORY NON-HEPATIC HYPERAMMONEMIA PRECIPITATED BY ENTEROVESICAL FISTULA
7. TREATMENT AND OUTCOMES IN PATIENTS HOSPITALIZED FOR SEPSIS WITH PULMONARY ARTERIAL HYPERTENSION COMPARED TO PATIENTS WITHOUT PULMONARY ARTERIAL HYPERTENSION
8. Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study
9. Pathogenesis, clinical features and phenotypes of pulmonary hypertension associated with interstitial lung disease A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension
10. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
11. Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension
12. Sex Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients With Pulmonary Embolism
13. Venoarterial Versus Venovenous Extracorporeal Membrane Oxygenation As Bridge to Lung Transplantation
14. POST HOC ANALYSIS OF CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) BY PULMONARY VASCULAR PHENOTYPE FROM CAPACITY
15. Outcomes and Prognostic Factors of Pulmonary Hypertension Patients Undergoing Emergent Endotracheal Intubation
16. Methamphetamine-associated pulmonary arterial hypertension
17. Postpulmonary Embolism Follow-Up and Epidemiology of Chronic Thromboembolic Pulmonary Hypertension
18. Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease
19. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension
20. The Role of EBP50 in Regulating Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension
21. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality
22. Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension
23. Diagnosis and Treatment of Pulmonary Sarcoidosis
24. A NOVEL USE OF VA-ECMO FOR RUPTURED APPENDICITIS IN A PATIENT WITH NON-COMPACTION CARDIOMYOPATHY AND SEVERE PULMONARY ARTERIAL HYPERTENSION
25. Subacute Dyspnea in a Young Woman with Newly Metastatic Breast Cancer
26. Update on Medical Management of Pulmonary Arterial Hypertension
27. The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation
28. Right Side of the Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure
29. Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension
30. OUTCOMES AND PROGNOSTIC FACTORS OF PULMONARY ARTERIAL HYPERTENSION PATIENTS UNDERGOING EMERGENT ENDOTRACHEAL INTUBATION
31. SCREENING FOR PULMONARY HYPERTENSION IN PATIENTS WITH INTERSTITIAL LUNG DISEASE: RECOMMENDATIONS FROM A DELPHI CONSENSUS PANEL
32. Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
33. RATE VS RHYTHM CONTROL IN A PATIENT WITH PULMONARY ARTERIAL HYPERTENSION AND ATRIAL FLUTTER: USE OF DIRECT HEMODYNAMIC MEASUREMENTS
34. Sweet’s Syndrome
35. Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement
36. 824 Case Series on the Use of Volume Assured Pressure Support in Patients with Chronic Pulmonary Disease and Progressive Hypercapnia
37. Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning
38. Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study
39. Long‐Term Outcomes in Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta‐Analyses of Randomized, Controlled Trials and Observational Registries
40. Brain Structural Changes in Patients with Pulmonary Arterial Hypertension
41. Left main coronary artery compression in pulmonary hypertension
42. Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
43. Radiographic and Histopathologic Features in Sarcoidosis: A Pictorial Display
44. A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation
45. 1262 Case Series on the Use of Volume Assured Pressure Support (VAPS) in Patients with Interstitial Lung Disease and Progressive Hypercapnia
46. Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction
47. Weight loss for critical care patient to improve lung transplantation candidacy: A case report
48. COUNTERPOINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? No
49. Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
50. Critical Care of Patients After Pulmonary Thromboendarterectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.